MAPLE GROVE, Minn. – Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., today announced the recent launch of Brimonidine Tartrate Ophthalmic Solution 0.1% and Brimonidine Tartrate Ophthalmic Solution 0.15%.
According to IQVIA, the Brimonidine Tartrate Ophthalmic Solution market for these dosage strengths had U.S. sales of approximately $115 million. Upsher-Smith’s Brimonidine Tartrate Ophthalmic Solution 0.1% has a Therapeutic Equivalence Code (TE) of AB, while the 0.15% strength has a TE code of AT. The Reference Listed Drug (RLD) for both products is the brand ALPHAGAN P.
Product | Strength | NDC # | Size & Package |
Brimonidine Tartrate Ophthalmic Solution | 0.1% | 0832-1435-05 | 5 mL solution in 10 mL bottle |
Brimonidine Tartrate Ophthalmic Solution | 0.1% | 0832-1435-10 | 10 mL solution in 10 mL bottle |
Brimonidine Tartrate Ophthalmic Solution | 0.1% | 0832-1435-15 | 15 mL solution in 15 mL bottle |
Brimonidine Tartrate Ophthalmic Solution | 0.15% | 0832-1420-05 | 5 mL solution in 10 mL bottle |
Brimonidine Tartrate Ophthalmic Solution | 0.15% | 0832-1420-10 | 10 mL solution in 10 mL bottle |
Brimonidine Tartrate Ophthalmic Solution | 0.15% | 0832-1420-15 | 15 mL solution in 15 mL bottle |
For questions about ordering, please call Upsher-Smith at 1-800-654-2299.
Please refer to the full Prescribing Information for Brimonidine Tartrate Ophthalmic Solution 0.1% here and Brimonidine Tartrate Ophthalmic Solution 0.15% here.You can also call 1-888-650-3789 to obtain a copy of the full Prescribing Information.
Patients are encouraged to report suspected adverse reactions to Upsher-Smith Laboratories, LLC at 1-855-899-9180 or to the FDA by visiting http://www.fda.gov/medwatch.
